Newbridge Financial Services Group, Inc. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
Newbridge Financial Services Group, Inc. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$6,280
-37.2%
2,0000.0%0.00%
-33.3%
Q3 2022$10,000
-16.7%
2,000
-33.3%
0.01%
-14.3%
Q2 2022$12,000
+33.3%
3,000
+100.0%
0.01%
+75.0%
Q1 2022$9,000
-18.2%
1,5000.0%0.00%
-20.0%
Q4 2021$11,000
-21.4%
1,5000.0%0.01%
-44.4%
Q3 2021$14,0001,5000.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
FIC CAPITAL INC 875,284$2,670,0001.34%
NEXTHERA CAPITAL LP 503,000$1,534,0000.90%
Opaleye Management Inc. 400,000$1,220,0000.72%
WASATCH ADVISORS LP 7,256,260$22,132,0000.33%
Cormorant Asset Management, LP 650,000$1,983,0000.27%
Sicart Associates LLC 101,950$311,0000.22%
Baker Brothers Advisors 4,055,876$12,370,0000.12%
Leisure Capital Management 43,008$131,0000.12%
Piermont Capital Management Inc. 165,569$505,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 837,963$2,556,0000.10%
View complete list of SANGAMO THERAPEUTICS INC shareholders